3,225
Views
37
CrossRef citations to date
0
Altmetric
Editorial

Cutting-edge technologies in colon-targeted drug delivery systems

, M. Pharm., Ph. D
Pages 1247-1258 | Published online: 20 Sep 2011

Bibliography

  • Patel M, Shah T, Amin A. Therapeutic opportunities in colon specific drug delivery systems. Crit Rev Ther Drug Carrier Syst 2007;24:147-202
  • Patel MM, Amin AA. Design and optimization of colon targeted system of theophylline for chronotherapy of nocturnal asthma. J Pharm Sci 2011;100:1760-72
  • Ashford M, Fell JT, Attwood D, An in vivo investigation into the suitability of pH dependent polymers for colonic targeting. Int J Pharm 1993;95:193-9
  • McConnell EL, Short MD, Basit AW. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man. J Control Release 2008;130:154-60
  • Matsuda KI, Takaya T, Shimoji F, Effect of food intake on the deliver of fluorescein as a model drug in colon delivery capsule after oral to beagle dogs. J Drug Target 1996;4:59-67
  • Patel MM, Shah TJ, Amin AF, Design, development and optimization of a novel time and pH-dependent colon targeted drug delivery system. Pharm Dev Technol 2009;14:62-9
  • Patel MM, Patel SL, Bhadani MN, A synchronous colon specific drug delivery system for orally administered mesalamine. Acta Pharm Sci 2009;51:251-60
  • Patel MM, Amin AA. Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer. Drug Deliv 2011;18:281-93
  • Ji C, Xu H, Wu W. In vitro evaluation and pharmacokinetics in dogs of guar gum and Eudragit® FS30D-coated colon-targeted pellets of indomethacin. J Drug Target 2007;15:123-31
  • Patel MM, Amin AF. Process, optimization and characterization of mebeverine hydrochloride loaded guar gum microspheres for irritable bowel syndrome. Carbohydr Polym 2011; published online 7 May 2011; doi:10.1016/j.carbpol.2011.04.068.
  • Moreto M, Gonalons E, Mylonakis N, 3,3-Bis-(4-hydroxyphenyl)-7-methyl-2-indolinone (BHMI), the active metabolite of the laxative sulisatin. Arzneimittel Forsch Drug Res 1979;29:1561-4
  • Csaky TZ. Pharmacology of intestinal permeation II. Springer-Verlag; Heidelberg: 1984
  • Wroblewski S, Rihova B, Rossmann P, The influence of a colonic microbiota on HPMA copolymer lectin conjugates binding in rodent intestine. J Drug Target 2001;9:85-94
  • Galanina O, Hallouin F, Goupille C, Detection of a potential receptor for the H-blood-group antigen on rat colon carcinoma cells and normal tissues. Int J Cancer 1998;76:136-40
  • Theresa MA. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002;2:750-63
  • Vila JI, Calpena AC, Obach R, Gastric intestinal and colonic absorption of a series of beta-blockers in the rat. Int J Clin Pharmacol Ther Toxicol 1992;30:280-6
  • Godbillon J, Evard D, Vidon N, Investigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon. Br J Clin Pharmacol 1985;19:113S-8S
  • Ishibashi T, Ikegami K, Kubo H, Evaluation of colonic absorbability of drugs in dogs using a novel colon targeted delivery capsules. J Control Release 1999;59:361-76
  • Lamprecht A, Scaffer U, Lehr CM. Size dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa. Pharm Res 2001;18:788-93
  • Lamprecht A, Ubrich N, Yamamoto H, Biodegradable nanoparticles for targeted drug delivery in treatment of inflammatory bowel disease. J Pharmacol Exp Ther 2001;299:775-81
  • Wilson DS, Dalmasso G, Wang L, Orally delivered thioketal nanoparticles loaded with TNF-alpha–siRNA target inflammation and inhibit gene expression in the intestines. Nat Mater 2010;9:923-8
  • Rubinstein A. Colonic drug delivery. Drug Discov Today Technol 2005;2:33-7
  • Rashid A. Dispensing device. EP0384642; 1990
  • Krogel I, Bodmeier R. Pulsatile drug release from an insoluble capsule body controlled by an insoluble plug. Pharm Res 1998;15:474-81
  • Stevens HNE, Ross AC, Johnson JR. The hydrophilic sandwich (HS) capsule: a convenient time-delayed oral probe device. J Pharm Pharmcol 2000;52:S41
  • Ueda S, Hata T, Asakura S, Development of a novel drug delivery system. Time-controlled Explosion System (TES). I. Concept and design. J Drug Target 1994;2:35-44
  • Pozzi F, Furlani P, Gazzaniga A, The Time Clock system: a new oral dosage form for fast and complete release of drug after a predetermined lag time. J Control Release 1994;31:99-108
  • Gazzaniga A, Sangalli ME, Giordano F. Oral Chronotopic drug delivery systems: achievement of time and/or site specificity. Eur J Pharm Biopharm 1994;40:246-50

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.